Page last updated: 2024-11-06

ethyl tyrosine ester

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ethyl tyrosine ester: RN given refers to L-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

ethyl L-tyrosinate : An L-tyrosyl ester that is L-tyrosine in which the hydrogen of the carboxy group has been replaced by an ethyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID70364
CHEMBL ID292389
CHEBI ID9798
SCHEMBL ID242947
MeSH IDM0147193

Synonyms (45)

Synonym
AKOS015838771
l-tyrosine, ethyl ester
ethyl l-tyrosinate
l-tyrosine ethyl ester
949-67-7
nsc-519993
tyrosine ethyl ester
C01458
tyr-oet
CHEMBL292389
chebi:9798 ,
l-tyrosine ethylester
ethyl (2s)-2-amino-3-(4-hydroxyphenyl)propanoate
T0551
h-tyr-oet
A845142
2-[4-(2,6-dichloro-4-nitro-phenyl)azo-n-(2-methoxycarbonyloxyethyl)-3-methyl-anilino]ethyl methyl carbonate;l-tyrosine ethyl ester
unii-17rpw76a9g
einecs 213-442-6
17rpw76a9g ,
nsc 519993
ethyl tyrosine ester
BBL009720
AKOS005716948
STL141085
SCHEMBL242947
(l)-tyrosine ethyl ester
l-tyrosine ethyl
(s)-2-amino-3-(4-hydroxy-phenyl)-propionic acid ethyl ester
l-tyrosine ethyl ester free base
(s)-ethyl 2-amino-3-(4-hydroxyphenyl)propanoate
l-tyr-oet
Q-101737
ethyl 2-amino-3-(4-hydroxyphenyl)propanoate #
mfcd00063046
l-tyrosine ethyl ester; tyrosine, ethyl ester, l- (6ci,8ci); (s)-tyrosine ethyl ester; ethyl (s)-2-amino-3-(4-hydroxyphenyl)propionate; ethyl l-tyrosinate; nsc 519993
l-tyrosineethylester
l tyrosine ethyl ester
Q27108499
AS-12776
H10794
ethyl-l-tyrosine
DTXSID20883574
EN300-4207604
CS-0137959
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
ethyl esterAny carboxylic ester resulting from the formal condensation of the carboxy group of a carboxylic acid with ethanol.
L-tyrosyl esterAn alpha-amino acid ester resulting from esterification of the carboxy group of L-tyrosine.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID26797Partition coefficient (logP)1987Journal of medicinal chemistry, Oct, Volume: 30, Issue:10
Quantitative structure-activity relationships of the bitter thresholds of amino acids, peptides, and their derivatives.
AID233318Bitter threshold value1987Journal of medicinal chemistry, Oct, Volume: 30, Issue:10
Quantitative structure-activity relationships of the bitter thresholds of amino acids, peptides, and their derivatives.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (36.36)18.7374
1990's1 (9.09)18.2507
2000's2 (18.18)29.6817
2010's4 (36.36)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.73

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.73 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.77 (4.65)
Search Engine Demand Index29.56 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.73)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]